Mesoporous Silica-Calcium Phosphate-Tuberculin Purified Protein Derivative Composites as an Effective Adjuvant for Cancer Immunotherapy
Article first published online: 7 JAN 2013
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Advanced Healthcare Materials
Volume 2, Issue 6, pages 863–871, June, 2013
How to Cite
Li, X., Wang, X., Sogo, Y., Ohno, T., Onuma, K. and Ito, A. (2013), Mesoporous Silica-Calcium Phosphate-Tuberculin Purified Protein Derivative Composites as an Effective Adjuvant for Cancer Immunotherapy. Advanced Healthcare Materials, 2: 863–871. doi: 10.1002/adhm.201200149
- Issue published online: 13 JUN 2013
- Article first published online: 7 JAN 2013
- Manuscript Revised: 28 AUG 2012
- Manuscript Received: 7 MAY 2012
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.